Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cellebrite DI (CLBT) Return on Equity (2022 - 2025)

Cellebrite DI's Return on Equity history spans 4 years, with the latest figure at 0.0% for Q4 2025.

  • Quarterly Return on Equity rose 1.0% to 0.0% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.0% through Dec 2025, up 1.0% year-over-year, with the annual reading at 0.0% for FY2025, 2.0% up from the prior year.
  • Return on Equity came in at 0.0% for Q4 2025, down from 0.0% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.0% in Q1 2023 to a low of 0.3% in Q1 2024.
  • The 4-year median for Return on Equity is 0.01% (2024), against an average of 0.04%.
  • Year-over-year, Return on Equity decreased -30bps in 2024 and then rose 29bps in 2025.
  • Cellebrite DI's Return on Equity stood at 0.03% in 2022, then grew by 22bps to 0.02% in 2023, then surged by 60bps to 0.01% in 2024, then surged by 119bps to 0.0% in 2025.
  • Per Business Quant, the three most recent readings for CLBT's Return on Equity are 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025).